A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
|Articles|August 23, 2006
Training of Operating Room Staff in Endoscopic Surgery Video
Author(s)Wendy K. Winer, RN, BSN, CNOR
OBGYN.net Conference Coverage - AAGL 2004
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of RealPlayer, available
Advertisement
Related to this article
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA removes boxed warnings from 3 more menopausal hormone therapy products
2
Choosing Among Hormonal and Nonhormonal VMS Therapies in Menopause
3
Top headlines in women's health from October 2026
4
FDA grants accelerated approval to DNA immunotherapy for adult recurrent respiratory papillomatosis
5